[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336787-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336787-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dysbiosis-in-human-urinary-microbiota-may-differentiate-patients-with-a-bladder-cancer","Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer","","Recent interest in noninvasive diagnostic approaches has highlighted urinary microbiota as a potential biomarker for bladder cancer. This study profiled urinary microbiota from 30 bladder cancer patients and 32 healthy controls using a targeted NGS protocol sequencing eight hypervariable regions of the 16S rRNA gene. Microbial composition was compared across taxonomic levels, showing no marked differences at higher ranks, but significantly lower diversity in patients. Differential analysis identified five genera enriched in cancer patients, while 40 genera showed reduced abundance, supporting biomarker potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dysbiosis-in-human-urinary-microbiota-may-differentiate-patients-with-a-bladder-cancer/336787/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dysbiosis-in-human-urinary-microbiota-may-differentiate-patients-with-a-bladder-cancer/336787.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was urinary microbiota measured in the study?","Question",{"text":63,"@type":64},"The study used a specific NGS protocol sequencing eight hypervariable regions of the 16S rRNA gene to profile urinary microbiota composition.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Were there differences in microbial composition at higher taxonomic levels?",{"text":68,"@type":64},"No notable differences were observed at the phylum, class, order, and family levels.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genera were most associated with bladder cancer in the differential analysis?",{"text":72,"@type":64},"Five genera—Rhodanobacter, Cutibacterium, Alloscardovia, Moryella, and Anaeroglobus—were significantly more abundant in bladder cancer patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336787,1790418944,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Article  \nDysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer  \nJulie A. Vendrell 1, Simon Cabello-Aguilar 1,2, Romain Senal 1,3, Elise Heckendorn 1, Steven Henry 4, Sylvain Godreuil 4 and Jérôme Solassol 1,5, *  \nCitation: Vendrell, J.A.;  \nCabello-Aguilar, S.; Senal, R.; Heckendorn, E.; Henry, S.; Godreuil, S.; Solassol, J. Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer. Int. J. Mol. Sci. 2024, 25, 10159. [https://](https://)[ ](https://)[doi.org/10.3390/ijms251810159](doi.org/10.3390/ijms251810159)  \nAcademic Editor: Georg C. Hutterer  \nReceived: 27 August 2024  \nRevised: 19 September 2024  \nAccepted: 19 September 2024  \nPublished: 21 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Laboratoire de Biologie des Tumeurs Solides, Département de Pathologie et Oncobiologie, CHU Montpellier, Université de Montpellier, 34295 Montpellier, France; [j-vendrell@chu-montpellier.fr](j-vendrell@chu-montpellier.fr) (J.A.V.); [s-cabelloaguilar@chu-montpellier.fr](s-cabelloaguilar@chu-montpellier.fr) (S.C.-A.); [r-senal@chu-montpellier.fr](r-senal@chu-montpellier.fr) (R.S.)  \n2 Montpellier BioInformatique pour le Diagnostic Clinique (MoBiDiC), Plateau de Médecine Moléculaire et Génomique (PMMG), CHU Montpellier, 34295 Montpellier, France  \n3 Institut du Cancer de Montpellier (ICM), Département de Biopathologie, 34295 Montpellier, France  \n4 Laboratoire de Bactériologie, CHU Montpellier, Université de Montpellier, 34295 Montpellier, France; [steven-henry@chu-montpellier.fr](steven-henry@chu-montpellier.fr) (S.H.); [s-godreuil@chu-montpellier.fr](s-godreuil@chu-montpellier.fr) (S.G.)  \n5 Institut Régional du Cancer de Montpellier (IRCM), Université de Montpellier, ICM, Inserm,  \n34298 Montpellier, France  \n* [Correspondence: j-solassol@chu-montpellier.fr](Correspondence: j-solassol@chu-montpellier.fr); Tel.: +33-4-6733-5871; Fax: +33-4-6733-9590  \nAbstract: Recent interest in noninvasive diagnostic approaches has highlighted the potential of urinary microbiota as a novel biomarker for bladder cancer. This study investigated the urinary microbiota of 30 bladder cancer patients and 32 healthy controls using a specific NGS protocol that sequences eight hypervariable regions of the 16S rRNA gene, providing detailed insights into urinary microbiota composition. The relative abundance of microbial compositions in urine samples from cancer patients and healthy controls was analyzed across various taxonomic levels. No notable differences were highlighted at the phylum, class, order, and family levels. At the genus level, 53% of detected genera were represented in either cancer patients or healthy controls. Microbial diversity was significantly lower in cancer patients. The differential analysis identified five genera, Rhodanobacter, Cutibacterium, Alloscardovia, Moryella, and Anaeroglobus, that were significantly more abundant in cancer patients. Notably, Rhodanobacter was present in 20 cancer samples but absent in healthy controls. Conversely, 40 genera, including Lactobacillus, Propionibacterium, and Bifidobacterium, exhibited reduced abundance in cancer patients. These findings suggest that some genera may serve as potential biomarkers for bladder cancer, highlighting the need for further research to explore their roles in disease pathogenesis and their potential applications in diagnostics and therapeutics.  \nKeywords: bladder cancer; urinary microbiota; NGS; Rhodanobacter; Cutibacterium  \n1. Introduction  \nBladder cancer affects over 600,000 individuals annually, resulting in more than 220,000 deaths worldwide, making it the ninth most prevalent ma","cbCaifnhvgJl5BFh","https://ap.wps.com/l/cbCaifnhvgJl5BFh","pdf",2244887,11,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How was urinary microbiota measured in the study?\",\"answer\":\"The study used a specific NGS protocol sequencing eight hypervariable regions of the 16S rRNA gene to profile urinary microbiota composition.\"},{\"question\":\"Were there differences in microbial composition at higher taxonomic levels?\",\"answer\":\"No notable differences were observed at the phylum, class, order, and family levels.\"},{\"question\":\"Which genera were most associated with bladder cancer in the differential analysis?\",\"answer\":\"Five genera—Rhodanobacter, Cutibacterium, Alloscardovia, Moryella, and Anaeroglobus—were significantly more abundant in bladder cancer patients.\"}]","Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer | PDF",1790016600,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/462d98c80aa4282e0be49f969b2c4c5b.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ef265865668e689d68314b2a8bc5b7e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3260229537e7cff7aa993c6dbc6160d.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c9324a81b56e0b030f95e866fab7687.webp",980,692]